What is CVS-3983?

CVS-3983 is an experimental antiviral drug developed by the pharmaceutical company CVS Health, primarily targeting viral infections. It is designed to inhibit viral replication and may be explored for treating various viral diseases. The specific details about its mechanisms, indications, or clinical trial status may vary, so it's best to consult recent scientific literature or clinical trial registries for the latest information.